ScholarIQanswers from OpenAlex & ORCID
Mark Haas
ResearcherPublications, citations & collaboration network
Mark Haas is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Mark Haas have?
ScholarIQindexed works
Mark Haas has 353 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Mark Haas have?
ScholarIQcitation count
Mark Haas has 38,104 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Mark Haas?
ScholarIQh-index
Mark Haas has an h-index of 93 in OpenAlex.
What is the i10-index of Mark Haas?
ScholarIQi10-index
Mark Haas has an i10-index of 230 in OpenAlex.
What is the ORCID of Mark Haas?
ScholarIQorcid
The ORCID for Mark Haas is on the source record.
What is the OpenAlex record for Mark Haas?
ScholarIQopenalex
The OpenAlex for Mark Haas is on the source record.
What are the most-cited papers on Mark Haas?
ScholarIQmost cited works
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
Kim Solez, Robert B. Colvin, Lorraine C. Racusen, Mark Haas, B. Sis, Michael Mengel, Philip F. Halloran, William M. Baldwin, G. Bánfi, A. Bernard Collins, Borja G. Cosío, Daísa Silva Ribeiro David, Cinthia B. Drachenberg, Gunilla Einecke, Agnes B. Fogo, Ian W. Gibson, Denis Glotz, Samy S. Iskandar, Edward S. Kraus, Evelyne Lerut, Roslyn B. Mannon, Michael J. Mihatsch, Brian J. Nankivell, Volker Nickeleit, John C. Papadimitriou, Parmjeet Randhawa, Heinz Regele, Karine Renaudin, Ian S.D. Roberts, Daniel Serón, R. Neal Smith, Marialuisa Valente
Pathologic Classification of Diabetic Nephropathy
Thijs W. Cohen Tervaert, Antien L. Mooyaart, Kerstin Amann, Arthur H. Cohen, H. Terence Cook, Cinthia B. Drachenberg, Franco Ferrario, Agnes B. Fogo, Mark Haas, Emile de Heer, Kensuke Joh, Laure Hélène Noël, Jai Radhakrishnan, Surya V. Seshan, Ingeborg M. Bajema, Jan A. Bruijn
VEGF Inhibition and Renal Thrombotic Microangiopathy
Vera Eremina, J. Ashley Jefferson, Jolanta Kowalewska, Howard S. Höchster, Mark Haas, Joseph Weisstuch, C. A. Richardson, Jeffrey B. Kopp, M. Golam Kabir, Peter H. Backx, Hans-Peter Gerber, N. Ferrara, Laura Barisoni, Charles E. Alpers, Susan E. Quaggin
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
Mark Haas, B. Sis, Lorraine C. Racusen, Kim Solez, Denis Glotz, Robert B. Colvin, Maria Cristina Ribeiro de Castro, Daísa Silva Ribeiro David, Elias David‐Neto, Serena M. Bagnasco, Linda C. Cendales, Lynn D. Cornell, A J Demetris, Cinthia B. Drachenberg, Carol Farver, Alton B. Farris, Ian W. Gibson, Edward S. Kraus, Helen Liapis, Alexandre Loupy, Volker Nickeleit, Parmjeet Randhawa, E. René Rodríguez, David N. Rush, R. Neal Smith, Carmela D. Tan, William D. Wallace, Michael Mengel
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification
A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Daniel C. Cattran, Rosanna Coppo, H. Terence Cook, John Feehally, Ian S.D. Roberts, Stéphan Troyanov, Charles E. Alpers, Alessandro Amore, Jonathan Barratt, F. Berthoux, Stephen M. Bonsib, Jan A. Bruijn, Vivette D. D’Agati, Giuseppe D’Amico, Steven N. Emancipator, Francesco Emma, Franco Ferrario, Fernando C. Fervenza, Sandrine Florquin, Agnes B. Fogo, Colin Geddes, Hermann-Josef Groene, Mark Haas, Andrew M. Herzenberg, Prue Hill, Ronald J. Hogg, Stephen I‐Hong Hsu, J. Charles Jennette, Kensuke Joh, Bruce A. Julian, Tetsuya Kawamura, Fernand Mac–Moune Lai, Chi Bon Leung, Lei-Shi Li, Philip Kam‐Tao Li, Zhi-Hong Liu, Bruce Mackinnon, Sergio Mezzano, Francesco Paolo Schena, Yasuhiko Tomino, Patrick D. Walker, Haiyan Wang, Jan J. Weening, Nori Yoshikawa, Hong Zhang